Substantia Nigra as Brainstem Signature in Pediatric‐Onset Huntington's Disease: The RAREST ‐ JHD Study
Movement Disorders Clinical Practice · 2025
DOI: 10.1002/mdc3.70382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Umberto Sabatini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Research Centre, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy. Hauptthemen laut MEDLINE: Huntington Disease, Substantia Nigra, Brain Stem. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministero della Salute, Fondazione Lega Italiana Ricerca Huntington.
Abstract (Originalsprache)
Background
Pediatric‐onset Huntington's disease (POHD) is usually associated with signs and symptoms of parkinsonism and dystonia predominating on chorea, which is typical of adult‐onset HD (AOHD). Brain changes responsible of such an atypical POHD phenotype remain poorly understood.
Objectives
To detect Midbrain and Substantia Nigra (SN) volumetric changes and their potential association with clinical parameters.
Methods
Cross‐sectional study by 3 T high‐field Magnetic Resonance Imaging and Unified Huntington Disease Rating Scales assays in POHD cohort with ≥60 CAG repeats and AOHD cohort with ≤59CAG repeats in HTT gene.
Results
POHD had volumes of SN lower than adult‐onset HD (AOHD) ( P = 0.003), in addition to lower striatum volume ( P < 0.05). The lower SN volume of the whole HD population correlated significantly with clinical measures of UHDRS motor ( P = 0.009), functional capacity ( P = 0.001) and independence ( P = 0.021) scores.
Conclusions
Our findings suggest SN volume decrease as potential POHD brain signature contributing to the atypical HD parkinsonism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuroscience Research Centre, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy.
- Unità Huntington e Malattie Rare, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
- Department of Clinical Psychology and Psychobiology, Neurosciences Institute, University of Barcelona, Barcelona, Spain.
- Neurology Department, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet DE Llobregat, Spain.
ORCID-Profile: Umberto Sabatini, Sabrina Maffi, Maria Eugenia Caligiuri, Cristina Sánchez-Castañeda, Emanuele Tinelli, Ferdinando Squitieri
Förderung
- Ministero della Salute
- Fondazione Lega Italiana Ricerca Huntington
Zitieren
APA
Sabatini, U., Maffi, S., Caligiuri, M. E., Sánchez-Castañeda, C., Tinelli, E., & Squitieri, F. (2025). Substantia Nigra as Brainstem Signature in Pediatric‐Onset Huntington's Disease: The RAREST ‐ JHD Study. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70382
Vancouver
Sabatini U, Maffi S, Caligiuri ME, Sánchez-Castañeda C, Tinelli E, Squitieri F. Substantia Nigra as Brainstem Signature in Pediatric‐Onset Huntington's Disease: The RAREST ‐ JHD Study. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70382
BibTeX
@article{Sabatini2025,
author = {Sabatini, Umberto and Maffi, Sabrina and Caligiuri, Maria Eugenia and Sánchez-Castañeda, Cristina and Tinelli, Emanuele and Squitieri, Ferdinando},
title = {Substantia Nigra as Brainstem Signature in Pediatric‐Onset Huntington's Disease: The RAREST ‐ JHD Study},
journal = {Movement Disorders Clinical Practice},
year = {2025},
doi = {10.1002/mdc3.70382}
}
EUVIMED